The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|August 2, 2001
- Pharmaceutical Technology-08-02-2001
- Volume 25
- Issue 8
Report on the Industry Blend Uniformity Practices Survey
The industry speaks out about how it conducts routine­ and validation­batch blend uniformity testing, to what it attributes failures associated with such tests, and its attitudes toward the use of new blend uniformity testing technologies.
Advertisement
Articles in this issue
about 25 years ago
Interphex Presents a Wide Array of Packaging Innovationsabout 25 years ago
Changes and Challenges for CDERAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
2
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
3
PharmTech Weekly Roundup—October 23, 2026: CMC Considerations, Rare Disease Development, Standards Harmonization
4
Why AI Model Updates Need Change Control: AAPS PharmSci 360 2026
5